Media Pack
News

Current Edition

JCS Volume 15 Issue 3
 
Ensuring Inspection Readiness at Clinical Facilities
Volume 11 Issue 5

Ensuring Inspection Readiness at Clinical Facilities

The principles of Good Clinical Practice (GCP) serve to ensure the protection of trial participants and the integrity of the data recorded. Katrien Lemmens at SGS Cl...
28 October 2019 Volume 11 Issue 5
Continue Reading →
Digesting the Alphabet Soup of Data Standards
Volume 11 Issue 5

Digesting the Alphabet Soup of Data Standards

Harmonisation of data standards has been a popular topic recently at the US Food and Drug Administration (FDA) and other regulatory organisations. Governmental regul...
28 October 2019 Volume 11 Issue 5
Continue Reading →
Successful Oncology Trials Need Intelligent Supply Management
Volume 11 Issue 5

Successful Oncology Trials Need Intelligent Supply Management

As clinical trials become more complex, so does the task of ensuring the right supplies are in the right place at the right time. Protocol changes, undefined doses, ...
28 October 2019 Volume 11 Issue 5
Continue Reading →
Planning for Early Access Programmes
Volume 11 Issue 5

Planning for Early Access Programmes

Early access programmes are becoming more common and more sophisticated, requiring greater attention and resources from sponsors. The FDA’s pilot programme is design...
28 October 2019 Volume 11 Issue 5
Continue Reading →
Living in the Data Stream: Managing Patient and Study Metrics
Volume 11 Issue 5

Living in the Data Stream: Managing Patient and Study Metrics

Clinical research is changing rapidly alongside the growing prevalence of “smart” technology. Data is being generated beyond traditional clinical settings – originat...
28 October 2019 Volume 11 Issue 5
Continue Reading →
Are Regulatory Service Providers Over-estimating AI’s Potential Impact on Process Transformation?
Volume 11 Issue 5

Are Regulatory Service Providers Over-estimating AI’s Potential Impact on Process Transformation?

Within the next three years, the pharma and biotech industries will be at a point of deploying AI and machine learning to transform the pace and productivity of rout...
28 October 2019 Volume 11 Issue 5
Continue Reading →
Adjust in Time: Beware of the Challenges Annex VI Brings for Labelling
Volume 11 Issue 5

Adjust in Time: Beware of the Challenges Annex VI Brings for Labelling

Five years after Clinical Trial Regulation (EU) first came into force, development of the clinical trials portal and database that will trigger its official applicat...
28 October 2019 Volume 11 Issue 5
Continue Reading →
EU Clinical Trials Regulation and Protection of Personal Data
Volume 11 Issue 5

EU Clinical Trials Regulation and Protection of Personal Data

Personal data concerning health should include all data pertaining to the health status of a data subject which reveal information relating to the past, current or f...
28 October 2019 Volume 11 Issue 5
Continue Reading →
The Public’s Growing Appetite for Product Data
Volume 11 Issue 5

The Public’s Growing Appetite for Product Data

As momentum builds anew towards ISO IDMP compliance, life sciences companies could be forgiven for a lacklustre response, after a series of delays. Most organisation...
28 October 2019 Volume 11 Issue 5
Continue Reading →
North Africa; an Underestimated Region with Huge Potential for Clinical Trials
Volume 11 Issue 5

North Africa; an Underestimated Region with Huge Potential for Clinical Trials

North Africa is the region covering the northern part of the African continent and can be defined as the area covering Morocco, Algeria, Tunisia, Libya, Egypt and Su...
28 October 2019 Volume 11 Issue 5
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2023, All Rights Reserved – Powered by Teksyte